Clinical Trial Update: A Study of Bevacizumab (Avastin) in Combination With Capecitabine (Xeloda) in Elderly Patients With Metastatic Colorectal Cancer [Phase 3]

View source ↗

Summary

Phase 3 study of bevacizumab (Avastin) plus capecitabine (Xeloda) in elderly patients with metastatic colorectal cancer; the trial completed and results were po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Xeloda (capecitabine)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Colorectal Cancer | Phase 3 | Status: COMPLETED | Results posted: 2014-06-10